Capricor Therapeutics Interview Guide

Capricor Therapeutics (NASDAQ: CAPR) is a pioneering biotechnology company located in San Diego, California, dedicated to developing transformative therapies for rare diseases, with a particular focus on Duchenne muscular dystrophy (DMD). Utilizing advanced cell therapy and exosome-based technology, Capricor has created innovative platforms, including its lead product, deramiocel (CAP-1002), and the proprietary StealthX™ platform. The company is committed to addressing the unmet medical needs of patients and is consistently pushing the boundaries of medical science. With a collaborative work environment and a strong emphasis on innovation, Capricor Therapeutics offers a dynamic place for professionals looking to make a significant impact in the field of biotechnology.